注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Cytokinetics Inc是一家后期生物制药公司。它专注于发现、开发和商业化肌肉激活剂和肌肉抑制剂,作为治疗衰弱性疾病的潜在疗法。它正在开发小分子候选药物,专门设计用于影响肌肉功能和收缩力。其临床阶段候选药物有:omecamtiv mecarbil,一种用于治疗射血分数降低的心力衰竭(HFrEF)的心肌肌球蛋白激活剂;CK-136,一种用于治疗心力衰竭和其他疾病的心肌肌钙蛋白激活剂;reldesemtiv(CK-2127107),一种快速骨骼肌肌钙蛋白激活剂(FSTA),用于治疗患有衰弱性疾病和肌肉无力相关疾病的患者;aficamten(CK-274),一种心肌肌球蛋白抑制剂,旨在降低肥厚型心肌病(HCM)相关的高收缩;第二种新型心肌肌球蛋白抑制剂CK-3772271(CK-271)。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
James H. Sabry | 64 | 1997 | Co-Founder & Chairman of Scientific Advisory Board |
Lawrence S. B. Goldstein | - | - | Member of Scientific Advisory Board |
Thomas D. Pollard | - | - | Member of Scientific Advisory Board |
Santo J. Costa | 76 | 2010 | Independent Director |
David J. Morgans | 69 | 2006 | Member of Scientific Advisory Board |
B. Lynne Parshall | 68 | 2013 | Independent Director |
Nancy J. Wysenski | 64 | 2020 | Independent Director |
Wendell D. Wierenga | 74 | 2011 | Independent Director |
John Tannahill Henderson | 78 | 2009 | Independent Chairman |
Sandford Drexel Smith | 75 | 2012 | Independent Director |
Roger A. Fielding | - | - | Member of Scientific Advisory Board |
David A. Kass | - | - | Member of Scientific Advisory Board |
John Lowe | - | - | Member of Scientific Advisory Board |
Brian M. Stoltz | - | - | Member of Scientific Advisory Board |
Edward M. Kaye | 73 | 2016 | Independent Director |
Paul A. Wender | - | - | Member of Scientific Advisory Board |
H. Lee Sweeney | - | - | Member of Scientific Advisory Board |
John Solaro | - | - | Member of Scientific Advisory Board |
James A. Spudich | 82 | 1997 | Co-Founder & Member of Scientific Advisory Board |
Robert A. Harrington | 63 | 2022 | Independent Director |
Muna Bhanji | 61 | 2021 | Independent Director |
Robert I. Blum | 60 | 2004 | CEO, President, Principal Financial Officer & Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核